Results 261 to 270 of about 112,082 (305)
Some of the next articles are maybe not open access.

Perioperative management of antihypertensive agents

Minerva Medica
A large proportion, possibly over half, of patients presenting for preoperative evaluation will be taking antihypertensive agents. The multiple classes of agents and their use in different combinations can make management decisions challenging. Poor blood pressure control and lack of evidence or conflicting evidence for certain agents can further ...
Jason F, Shiffermiller   +2 more
openaire   +2 more sources

Antihypertensive Agents 1962–1968

1969
Seven years ago Schlittler, Druey, and Marxer [207] reported on antihypertensive agents in a previous volume of this series. Since this review appeared, research in the field of antihypertensive drugs has made steady progress. Although spectacular breakthroughs — exemplified by such pioneering feats as the discoveries of reserpine, hydralazine ...
O, Schier, A, Marxer
openaire   +2 more sources

Chapter 6 Antihypertensive Agents

1990
Publisher Summary Cardiovascular disease accounts for more expenditures on health care than any other diagnostic category and hypertension is the most prevalent cardiovascular condition. While unit costs for hypertension treatment are low, aggregate costs are enormous because of the large and growing population of patients who are treated ...
Edward W. Petriilo   +2 more
openaire   +1 more source

Antihypertensive Agents

International Anesthesiology Clinics, 1968
openaire   +3 more sources

Haemodynamic effects of antihypertensive agents

1978
In most patients with hypertension the cause is unknown and so are most of the mechanisms initiating and maintaining the elevated blood pressure. If these mechanisms were fully understood and were correctable by drugs, a truly rational therapy would be possible.
openaire   +2 more sources

Antihypertensive Agents and Incident Alzheimer's Disease: A Systematic Review and Meta-Analysis of Observational Studies

journal of prevention of Alzheimer's disease, The, 2022
Robert Howard   +2 more
exaly  

Antihypertensive agents in Alzheimer’s disease: beyond vascular protection

Expert Review of Neurotherapeutics, 2020
Thibaud Lebouvier   +2 more
exaly  

Home - About - Disclaimer - Privacy